503 Backend fetch failed

Error 503 Backend fetch failed

Backend fetch failed

Guru Meditation:

XID: 400064537


Varnish cache server

  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BeiGene, Ltd.
  6. News
  7. Summary
    BGNE   US07725L1026

BEIGENE, LTD.

(BGNE)
  Report
Delayed Nasdaq  -  04:00 2022-08-09 pm EDT
197.62 USD   -2.28%
11:48aJPMorgan Assumes BeiGene at Overweight with $296 Price Target
MT
10:28aNovartis-BeiGene Liver Cancer Drug Works As Well As Bayer's Nexavar in Phase 3 Study
MT
06:02aBeiGene Announces Positive Global Phase 3 Trial Results for PD-1 Inhibitor Tislelizumab in First-Line Unresectable Hepatocellular Cancer
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Asian ADRs Climb Higher in Friday Trading

06/24/2022 | 10:40am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ASLAN PHARMACEUTICALS LIMITED 2.79% 0.5499 Delayed Quote.-50.90%
BEIGENE, LTD. -2.28% 197.62 Delayed Quote.-27.06%
CHEETAH MOBILE INC. 0.12% 0.7389 Delayed Quote.-46.07%
CHINA ONLINE EDUCATION GROUP 0.63% 1.61 Delayed Quote.32.23%
ICICI BANK LIMITED -0.15% 836.95 Delayed Quote.13.08%
INFOSYS LIMITED 0.17% 1619.4 Delayed Quote.-14.22%
IQIYI, INC. -6.38% 3.67 Delayed Quote.-19.52%
JUPAI HOLDINGS LIMITED -16.67% 0.05 Delayed Quote.-95.15%
MELCO HOLDINGS INC. 0.00% 3460 Delayed Quote.-13.15%
MELCO RESORTS & ENTERTAINMENT LIMITED -2.64% 5.17 Delayed Quote.-49.21%
PERUSAHAAN PERSEROAN (PERSERO) PT TELEKOMUNIKASI INDONESIA TBK -1.28% 4640 End-of-day quote.14.85%
PINTEC TECHNOLOGY HOLDINGS LIMITED -1.75% 1.12 Delayed Quote.-49.19%
SEA LIMITED -2.35% 83.53 Delayed Quote.-62.66%
SIFY TECHNOLOGIES LIMITED -4.66% 2.25 Delayed Quote.-30.34%
THE9 LIMITED -8.39% 1.42 Delayed Quote.-78.81%
All news about BEIGENE, LTD.
11:48aJPMorgan Assumes BeiGene at Overweight with $296 Price Target
MT
10:28aNovartis-BeiGene Liver Cancer Drug Works As Well As Bayer's Nexavar in Phase 3 Study
MT
06:02aBeiGene Announces Positive Global Phase 3 Trial Results for PD-1 Inhibitor Tislelizumab..
BU
08/08BEIGENE, LTD. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
08/08Nomura Adjusts BeiGene's Price Target to $286.31 From $277.35, Maintains Buy Rating
MT
08/08Nomura Adjusts Beigene's Price Target to HK$172.89 From HK$167.48, Keeps at Buy
MT
08/05WALL STREET STOCK EXCHANGE : Another case of good news is bad news
MS
08/05ANALYST RECOMMENDATIONS : Eli Lilly, KLA, Kellogg, Epam Systems, BeiGene...
MS
08/05BeiGene Shares Gain After Doubling of Second-Quarter Revenue
DJ
08/04BeiGene Q2 Net Loss per ADS Widens as Revenue Rises; Shares Surge
MT
More news
Analyst Recommendations on BEIGENE, LTD.
More recommendations
Financials (USD)
Sales 2022 1 394 M - -
Net income 2022 -1 619 M - -
Net cash 2022 2 960 M - -
P/E ratio 2022 -16,2x
Yield 2022 -
Capitalization 20 447 M 20 447 M -
EV / Sales 2022 12,5x
EV / Sales 2023 8,83x
Nbr of Employees 8 500
Free-Float 99,0%
Chart BEIGENE, LTD.
Duration : Period :
BeiGene, Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BEIGENE, LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Last Close Price 197,62 $
Average target price 275,30 $
Spread / Average Target 39,3%
EPS Revisions
Managers and Directors
John V. Oyler Director
Xiao Bin Wu President & Chief Operating Officer
Julia Wang Chief Financial & Accounting Officer
Lai Wang Global Head-Research & Development
Christiane Langer Senior Vice President-Global Medical Affairs
Sector and Competitors
1st jan.Capi. (M$)
BEIGENE, LTD.-27.06%20 926
GILEAD SCIENCES, INC.-15.87%77 266
VERTEX PHARMACEUTICALS31.16%75 386
REGENERON PHARMACEUTICALS, INC.-2.84%67 420
BIONTECH SE-28.97%41 143
WUXI APPTEC CO., LTD.-20.94%40 375